Bayesian Adaptive Trials for Comparative Effectiveness Research: An Example in Status Epilepticus

Por Connor, Jason T., Elm, Jordan J., Brogliofor, Kristine R.
Publicado em 2013

Bayesian multiple imputation for missing multivariate longitudinal data from a Parkinson’s disease clinical trial

Por Luo, Sheng, Lawson, Andrew B, He, Bo, Elm, Jordan J, Tilley, Barbara C
Publicado em 2012

Long Term Understanding of Study Information in Research Participants with Parkinson's disease

Por Ravina, Bernard, Swearingen, Christopher, Elm, Jordan, Kamp, Cornelia, Kieburtz, Karl, Kim, Scott Y. H.
Publicado em 2009

Predictors of Cognitive Outcomes in Early Parkinson Disease Patients: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience

Por Schneider, Jay S., Elm, Jordan J., Parashos, Sotirios A., Ravina, Bernard M., Galpern, Wendy R.
Publicado em 2010

Two-arm randomised futility trials: PD-stat - a futility trial of a potential neuroprotective treatment in people with Parkinson's disease

Por Creanor, Siobhan, Vickery, Jane, Eyre, Vicky, Zajicek, John, Ball, Sue, Elm, Jordan, Carroll, Camille
Publicado no Trials (2015)

Flexible Analytical methods for Adding a Treatment Arm Mid-study to an Ongoing Clinical Trial

Por Elm, Jordan J., Palesch, Yuko Y., Koch, Gary G., Hinson, Vanessa, Ravina, Bernard, Zhao, Wenle
Publicado em 2012

Malignant Melanoma in Early-Treated Parkinson's Disease: The NET-PD Trial

Por Constantinescu, Radu, Elm, Jordan, Auinger, Peggy, Sharma, Saloni, Augustine, Erika F., Khadim, Laith, Kieburtz, Karl
Publicado no Mov Disord (2013)

Human Data Supporting Glyburide in Ischemic Stroke

Por Sheth, Kevin N., Simard, J. Marc, Elm, Jordan, Kronenberg, Golo, Kunte, Hagen, Kimberly, W. Taylor
Publicado no Acta Neurochir Suppl (2016)

Pilot study of atomoxetine in patients with Parkinson’s disease and dopa-unresponsive Freezing of Gait

Por Revuelta, Gonzalo J., Embry, Aaron, Elm, Jordan J., Gregory, Chris, Delambo, Amy, Kautz, Steve, Hinson, Vanessa K.
Publicado no Transl Neurodegener (2015)

Validation of an Ambulatory Capacity Measure in Parkinson Disease: A Construct Derived from the Unified Parkinson’s Disease Rating Scale

Por Parashos, Sotirios A., Elm, Jordan, Boyd, James T., Chou, Kelvin L., Dai, Lin, Mari, Zoltan, Morgan, John C., Sudarsky, Lewis, Wielinski, Catherine L.
Publicado no J Parkinsons Dis (2015)

Using Global Statistical Tests in Long-Term Parkinson’s Disease Clinical Trials

Por Huang, Peng, Goetz, Christopher G., Woolson, Robert F., Tilley, Barbara, Kerr, Douglas, Palesch, Yuko, Elm, Jordan, Ravina, Bernard, Bergmann, Kenneth J., Kieburtz, Karl
Publicado em 2009

Screen Failure Data in Clinical Trials: Are Screening Logs Worth It?

Por Elm, Jordan J., Palesch, Yuko, Easton, J. Donald, Lindblad, Anne, Barsan, William, Silbergleit, Robert, Conwit, Robin, Dillon, Catherine, Farrant, Mary, Battenhouse, Holly, Perlmutter, Aaron, Johnston, S. Claiborne
Publicado no Clin Trials (2014)

Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: rationale and design

Por Johnston, S. Claiborne, Easton, J. Donald, Farrant, Mary, Barsan, William, Battenhouse, Holly, Conwit, Robin, Dillon, Catherine, Elm, Jordan, Lindblad, Anne, Morgenstern, Lewis, Poisson, Sharon N., Palesch, Yuko
Publicado no Int J Stroke (2013)

The Established Status Epilepticus Trial 2013

Por Bleck, Thomas, Cock, Hannah, Chamberlain, James, Cloyd, James, Connor, Jason, Elm, Jordan, Fountain, Nathan, Jones, Elizabeth, Lowenstein, Daniel, Shinnar, Shlomo, Silbergleit, Robert, Treiman, David, Trinka, Eugen, Kapur, Jaideep
Publicado em 2013

A randomized recruitment intervention trial in Parkinson's disease to increase participant diversity: early stopping for lack of efficacy

Por Tilley, Barbara C, Mainous, Arch G, Elm, Jordan J, Pickelsimer, Elisabeth, Soderstrom, Lea H, Ford, Marvella E, Diaz, Vanessa A, Siminoff, Laura A, Burau, Keith, Smith, Daniel W
Publicado no Clin Trials (2012)

Glyburide is associated with attenuated vasogenic edema in stroke patients

Por Kimberly, W. Taylor, Battey, Thomas W. K., Pham, Ly, Wu, Ona, Yoo, Albert J., Furie, Karen L., Singhal, Aneesh B., Elm, Jordan J., Stern, Barney J., Sheth, Kevin N.
Publicado no Neurocrit Care (2014)

Validating Imaging Biomarkers of Cerebral Edema in Patients with Severe Ischemic Stroke

Por Yoo, Albert J., Sheth, Kevin N., Kimberly, W. Taylor, Chaudhry, Zeshan A., Elm, Jordan J., Jacobson, Sven, Davis, Stephen M., Donnan, Geoffrey A., Albers, Gregory W., Stern, Barney J., González, R. Gilberto
Publicado em 2012

Peripheral Biomarkers of Parkinson’s Disease Progression and Pioglitazone Effects

Por Simon, David K., Simuni, Tanya, Elm, Jordan, Clark-Matott, Joanne, Graebner, Allison K., Baker, Liana, Dunlop, Susan R., Emborg, Marina, Kamp, Cornelia, Morgan, John C., Ross, G. Webster, Sharma, Saloni, Ravina, Bernard
Publicado no J Parkinsons Dis (2015)

Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials by Use of a Utility-Weighted Modified Rankin Scale

Por Chaisinanunkul, Napasri, Adeoye, Opeolu, Lewis, Roger J., Grotta, James C., Broderick, Joseph, Jovin, Tudor G., Nogueira, Raul G., Elm, Jordan, Graves, Todd, Berry, Scott, Lees, Kennedy R., Barreto, Andrew D., Saver, Jeffrey L.
Publicado no Stroke (2015)

Sex Differences in Clinical Features of Early, Treated Parkinson’s Disease

Por Augustine, Erika F., Pérez, Adriana, Dhall, Rohit, Umeh, Chizoba C., Videnovic, Aleksandar, Cambi, Franca, Wills, Anne-Marie A., Elm, Jordan J., Zweig, Richard M., Shulman, Lisa M., Nance, Martha A., Bainbridge, Jacquelyn, Suchowersky, Oksana
Publicado no PLoS One (2015)